Los Angeles Capital Management LLC Alnylam Pharmaceuticals, Inc. Transaction History
Los Angeles Capital Management LLC
- $24.7 Billion
- Q3 2024
A detailed history of Los Angeles Capital Management LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 137,017 shares of ALNY stock, worth $32.7 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
137,017
Previous 1,188
11433.42%
Holding current value
$32.7 Million
Previous $288,000
12986.81%
% of portfolio
0.15%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ALNY
# of Institutions
643Shares Held
109MCall Options Held
1.28MPut Options Held
1.21M-
Capital World Investors Los Angeles, CA16.5MShares$3.94 Billion0.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.6MShares$3.02 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.28 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA5.24MShares$1.25 Billion0.31% of portfolio
-
Wellington Management Group LLP Boston, MA4.95MShares$1.18 Billion0.24% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $29.4B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...